Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors

BACKGROUND: Gut microbiota composition can influence cancer immunotherapy response. Recent evidence suggests Helicobacter pylori infection may reduce immune checkpoint inhibitor (ICI) efficacy in lung cancer and melanoma, but thorough characterization of this association in patients with gastric can...

Descripción completa

Detalles Bibliográficos
Autores principales: Magahis, Patrick T, Maron, Steven B, Cowzer, Darren, King, Stephanie, Schattner, Mark, Janjigian, Yelena, Faleck, David, Laszkowska, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619027/
https://www.ncbi.nlm.nih.gov/pubmed/37899129
http://dx.doi.org/10.1136/jitc-2023-007699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619027/
https://www.ncbi.nlm.nih.gov/pubmed/37899129
http://dx.doi.org/10.1136/jitc-2023-007699

Ejemplares similares